Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
暂无分享,去创建一个
C. Dejong | I. B. Borel Rinkes | O. Dekkers | C. V. van Eijck | H. van Goor | M. Drent | B. Bonsing | G. Valk | W. D. de Herder | P. Bisschop | M. Vriens | E. N. V. Nieveen van Dijkum | B. Havekes | C. Pieterman | S. Nell | A. C. van de Ven | W. M. Vorselaars | D. van Beek | A. V. D. van der Horst-Schrivers | P. H. O. M. M. L. B. W. W. A. N. A. C. R. C. A. C. Bisschop Dekkers Drent Havekes de Herder van der
[1] S. Sadowski,et al. Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk? , 2020, American journal of surgery.
[2] I. B. Borel Rinkes,et al. Surgery for multiple endocrine neoplasia type 1‐related insulinoma: long‐term outcomes in a large international cohort , 2020, The British journal of surgery.
[3] Jeffrey E. Lee,et al. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors , 2020, Pancreas.
[4] I. B. Borel Rinkes,et al. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG) , 2019, Journal of surgical oncology.
[5] U. Boggi,et al. Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. , 2019, Annals of surgery.
[6] Henry W. Long,et al. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors , 2019, Nature Medicine.
[7] P. Chanson,et al. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1 , 2018, Annals of surgery.
[8] D. Raptis,et al. Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[9] J. Barkun,et al. Toward a Consensus on Centralization in Surgery , 2018, Annals of surgery.
[10] R. Jensen,et al. Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms , 2018, Neuroendocrinology.
[11] G. Valk,et al. ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1 , 2018, Endocrine connections.
[12] I. B. Borel Rinkes,et al. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment. , 2018, European journal of endocrinology.
[13] I. B. Borel Rinkes,et al. Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors , 2018, Journal of Endocrinological Investigation.
[14] I. B. Borel Rinkes,et al. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1—Results From the Dutch MEN1 Study Group , 2017, The Journal of clinical endocrinology and metabolism.
[15] O. Dekkers,et al. Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[16] G. Gronchi,et al. Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up , 2017, World Journal of Surgery.
[17] E. Baudin,et al. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study , 2017, Annals of surgery.
[18] I. B. Borel Rinkes,et al. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm Results From the DutchMEN1 Study Group , 2017, Annals of surgery.
[19] M. Brandi,et al. Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate , 2017, Surgery.
[20] D. Gouma,et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.
[21] G. Thompson,et al. Long‐term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours , 2017, Clinical endocrinology.
[22] D. Gouma,et al. Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery , 2017, Surgery.
[23] O. Dekkers,et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients , 2016, BMC Medicine.
[24] R. Jensen,et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors , 2016, Neuroendocrinology.
[25] R. Thakker,et al. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1. , 2015, The lancet. Diabetes & endocrinology.
[26] P. Herscovitch,et al. Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. , 2015, Journal of the American College of Surgeons.
[27] M. Carty,et al. The influence of volume and experience on individual surgical performance: a systematic review. , 2015, Annals of surgery.
[28] P. Chanson,et al. Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study. , 2015, European journal of endocrinology.
[29] G. Valk,et al. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. , 2014, Endocrine-related cancer.
[30] V. Fendrich,et al. Enucleation and Limited Pancreatic Resection Provide Long-Term Cure for Insulinoma in Multiple Endocrine Neoplasia Type 1 , 2013, Neuroendocrinology.
[31] J. Barkun,et al. The Comprehensive Complication Index: A Novel Continuous Scale to Measure Surgical Morbidity , 2013, Annals of surgery.
[32] R. Jensen,et al. Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study , 2013, Medicine.
[33] M. Falconi,et al. Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1 , 2013, Annals of surgery.
[34] J. Bilezikian,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.
[35] D. Gouma,et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality , 2012, The British journal of surgery.
[36] Jeffrey E. Lee,et al. Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. , 2011, Surgery.
[37] V. Fendrich,et al. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1 , 2011, Langenbeck's Archives of Surgery.
[38] M. Koch,et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. , 2011, Surgery.
[39] A. Scarpa,et al. Presentation and Outcome of Pancreaticoduodenal Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome , 2011, Neuroendocrinology.
[40] A. Tabarin,et al. Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients , 2010, World Journal of Surgery.
[41] D. Farley,et al. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. , 2007, Surgery.
[42] D. Gouma,et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). , 2007, Surgery.
[43] Abe Fingerhut,et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. , 2007, Surgery.
[44] M. Brandi,et al. Pancreatectomy in Multiple Endocrine Neoplasia Type 1-Related Gastrinomas and Pancreatic Endocrine Neoplasias , 2006, Annals of surgery.
[45] J. Chayvialle,et al. Epidemiology Data on 108 MEN 1 Patients From the GTE With Isolated Nonfunctioning Tumors of the Pancreas , 2006, Annals of surgery.
[46] M. Rothmund,et al. Outcome of Duodenopancreatic Resections in Patients With Multiple Endocrine Neoplasia Type 1 , 2005, Annals of surgery.
[47] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[48] R. Jensen,et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. , 2001, The Journal of clinical endocrinology and metabolism.
[49] J. Norton,et al. Comparison of Surgical Results in Patients With Advanced and Limited Disease With Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome , 2001, Annals of surgery.
[50] J. Norton,et al. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. , 2000, Annals of surgery.
[51] P. Ruszniewski,et al. Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .
[52] A. Isidori,et al. Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm. , 2019, The Journal of clinical endocrinology and metabolism.
[53] G. Valk,et al. 'Quality in, quality out', a stepwise approach to EBM for rare diseases promoted by MEN1. , 2018, Endocrine connections.
[54] M. Büchler,et al. Use and results of consensus definitions in pancreatic surgery: a systematic review. , 2014, Surgery.
[55] T. Kent,et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. , 2013, Journal of the American College of Surgeons.